Greyhounds have a higher risk of bleeding disorders compared to other breeds. It is essential to identify and address this susceptibility before any surgical procedure. Tranexamic acid, an antifibrinolytic agent, is commonly administered to Greyhounds as a preventative measure to minimise bleeding during surgery. By inhibiting the breakdown of blood clots, tranexamic acid helps maintain haemostasis, ensuring a safer surgical experience for these unique dogs.
Additionally, Greyhounds exhibit a higher likelihood of developing hyperkalemia, an elevated level of potassium in the blood. During anaesthesia, it becomes crucial to monitor their electrolyte levels to avoid potential complications. Hyperkalemia can lead to severe cardiac abnormalities, necessitating vigilant measurement and management of electrolyte balance in Greyhounds throughout the anaesthesia process.